138 related articles for article (PubMed ID: 34906453)
1. Quantifying prediction of pathogenicity for within-codon concordance (PM5) using 7541 functional classifications of BRCA1 and MSH2 missense variants.
Loong L; Cubuk C; Choi S; Allen S; Torr B; Garrett A; Loveday C; Durkie M; Callaway A; Burghel GJ; Drummond J; Robinson R; Berry IR; Wallace A; Eccles DM; Tischkowitz M; Ellard S; Ware JS; Hanson H; Turnbull C;
Genet Med; 2022 Mar; 24(3):552-563. PubMed ID: 34906453
[TBL] [Abstract][Full Text] [Related]
2. Informing variant assessment using structured evidence from prior classifications (PS1, PM5, and PVS1 sequence variant interpretation criteria).
Bhat V; Adzhubei IA; Fife JD; Lebo M; Cassa CA
Genet Med; 2023 Jan; 25(1):16-26. PubMed ID: 36305854
[TBL] [Abstract][Full Text] [Related]
3. Exceptions to the rule: case studies in the prediction of pathogenicity for genetic variants in hereditary cancer genes.
Rosenthal ET; Bowles KR; Pruss D; van Kan A; Vail PJ; McElroy H; Wenstrup RJ
Clin Genet; 2015 Dec; 88(6):533-41. PubMed ID: 25639900
[TBL] [Abstract][Full Text] [Related]
4. Clinical Variant Classification: A Comparison of Public Databases and a Commercial Testing Laboratory.
Gradishar W; Johnson K; Brown K; Mundt E; Manley S
Oncologist; 2017 Jul; 22(7):797-803. PubMed ID: 28408614
[TBL] [Abstract][Full Text] [Related]
5. Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation.
Abkevich V; Zharkikh A; Deffenbaugh AM; Frank D; Chen Y; Shattuck D; Skolnick MH; Gutin A; Tavtigian SV
J Med Genet; 2004 Jul; 41(7):492-507. PubMed ID: 15235020
[TBL] [Abstract][Full Text] [Related]
6. Interpreting missense variants: comparing computational methods in human disease genes CDKN2A, MLH1, MSH2, MECP2, and tyrosinase (TYR).
Chan PA; Duraisamy S; Miller PJ; Newell JA; McBride C; Bond JP; Raevaara T; Ollila S; Nyström M; Grimm AJ; Christodoulou J; Oetting WS; Greenblatt MS
Hum Mutat; 2007 Jul; 28(7):683-93. PubMed ID: 17370310
[TBL] [Abstract][Full Text] [Related]
7. Systematic misclassification of missense variants in BRCA1 and BRCA2 "coldspots".
Dines JN; Shirts BH; Slavin TP; Walsh T; King MC; Fowler DM; Pritchard CC
Genet Med; 2020 May; 22(5):825-830. PubMed ID: 31911673
[TBL] [Abstract][Full Text] [Related]
8. In silico analysis of BRCA1 and BRCA2 missense variants and the relevance in molecular genetic testing.
Poon KS
Sci Rep; 2021 May; 11(1):11114. PubMed ID: 34045478
[TBL] [Abstract][Full Text] [Related]
9. Multifactorial likelihood assessment of BRCA1 and BRCA2 missense variants confirms that BRCA1:c.122A>G(p.His41Arg) is a pathogenic mutation.
Whiley PJ; Parsons MT; Leary J; Tucker K; Warwick L; Dopita B; Thorne H; Lakhani SR; Goldgar DE; Brown MA; Spurdle AB
PLoS One; 2014; 9(1):e86836. PubMed ID: 24489791
[TBL] [Abstract][Full Text] [Related]
10. Tumour characteristics provide evidence for germline mismatch repair missense variant pathogenicity.
Li S; Qian D; Thompson BA; Gutierrez S; Wu S; Pesaran T; LaDuca H; Lu HM; Chao EC; Black MH
J Med Genet; 2020 Jan; 57(1):62-69. PubMed ID: 31391288
[TBL] [Abstract][Full Text] [Related]
11. Variant classification changes over time in BRCA1 and BRCA2.
Mighton C; Charames GS; Wang M; Zakoor KR; Wong A; Shickh S; Watkins N; Lebo MS; Bombard Y; Lerner-Ellis J
Genet Med; 2019 Oct; 21(10):2248-2254. PubMed ID: 30971832
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction models.
Hart SN; Hoskin T; Shimelis H; Moore RM; Feng B; Thomas A; Lindor NM; Polley EC; Goldgar DE; Iversen E; Monteiro ANA; Suman VJ; Couch FJ
Genet Med; 2019 Jan; 21(1):71-80. PubMed ID: 29884841
[TBL] [Abstract][Full Text] [Related]
13. Performance of in silico prediction tools for the classification of rare BRCA1/2 missense variants in clinical diagnostics.
Ernst C; Hahnen E; Engel C; Nothnagel M; Weber J; Schmutzler RK; Hauke J
BMC Med Genomics; 2018 Mar; 11(1):35. PubMed ID: 29580235
[TBL] [Abstract][Full Text] [Related]
14. Impact of proactive high-throughput functional assay data on BRCA1 variant interpretation in 3684 patients with breast or ovarian cancer.
Kim HK; Lee EJ; Lee YJ; Kim J; Kim Y; Kim K; Lee SW; Chang S; Lee YJ; Lee JW; Lee W; Chun S; Son BH; Jung KH; Kim YM; Min WK; Ahn SH
J Hum Genet; 2020 Mar; 65(3):209-220. PubMed ID: 31907386
[TBL] [Abstract][Full Text] [Related]
15. Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants.
Lovelock PK; Healey S; Au W; Sum EY; Tesoriero A; Wong EM; Hinson S; Brinkworth R; Bekessy A; Diez O; Izatt L; Solomon E; Jenkins M; Renard H; Hopper J; Waring P; Tavtigian SV; Goldgar D; Lindeman GJ; Visvader JE; Couch FJ; Henderson BR; Southey M; Chenevix-Trench G; Spurdle AB; Brown MA;
J Med Genet; 2006 Jan; 43(1):74-83. PubMed ID: 15923272
[TBL] [Abstract][Full Text] [Related]
16. Calibration of multiple in silico tools for predicting pathogenicity of mismatch repair gene missense substitutions.
Thompson BA; Greenblatt MS; Vallee MP; Herkert JC; Tessereau C; Young EL; Adzhubey IA; Li B; Bell R; Feng B; Mooney SD; Radivojac P; Sunyaev SR; Frebourg T; Hofstra RM; Sijmons RH; Boucher K; Thomas A; Goldgar DE; Spurdle AB; Tavtigian SV
Hum Mutat; 2013 Jan; 34(1):255-65. PubMed ID: 22949387
[TBL] [Abstract][Full Text] [Related]
17. Substantial evidence for the clinical significance of missense variant BRCA1 c.5309G>T p.(Gly1770Val).
Tudini E; Moghadasi S; Parsons MT; van der Kolk L; van den Ouweland AMW; Niederacher D; Feliubadaló L; Wappenschmidt B; Spurdle AB; Lazaro C
Breast Cancer Res Treat; 2018 Nov; 172(2):497-503. PubMed ID: 30105462
[TBL] [Abstract][Full Text] [Related]
18. Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genes.
Cubuk C; Garrett A; Choi S; King L; Loveday C; Torr B; Burghel GJ; Durkie M; Callaway A; Robinson R; Drummond J; Berry I; Wallace A; Eccles D; Tischkowitz M; Whiffin N; Ware JS; Hanson H; Turnbull C; CanVIG-Uk
Genet Med; 2021 Nov; 23(11):2096-2104. PubMed ID: 34230640
[TBL] [Abstract][Full Text] [Related]
19. A new bioinformatics tool to help assess the significance of BRCA1 variants.
Cusin I; Teixeira D; Zahn-Zabal M; Rech de Laval V; Gleizes A; Viassolo V; Chappuis PO; Hutter P; Bairoch A; Gaudet P
Hum Genomics; 2018 Jul; 12(1):36. PubMed ID: 29996917
[TBL] [Abstract][Full Text] [Related]
20. Consistency of
Lincoln SE; Yang S; Cline MS; Kobayashi Y; Zhang C; Topper S; Haussler D; Paten B; Nussbaum RL
JCO Precis Oncol; 2017 Jul; 1():. PubMed ID: 28782058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
